Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Inverted Microscope Designed to Readily Adapt to Changing Research Demands

By LabMedica International staff writers
Posted on 16 Sep 2014
A new inverted microscope for biotech and other life science laboratories was designed to readily accommodate modifications and upgrades to allow it to keep current with changing research demands and interests.

Modularity is the key concept defining the new Leica Microsystems (Wetzlar, Germany) DMi8 inverted microscope, and the core of this concept is the unique illumination port, the "Infinity Port." This port facilitates the integration of additional light sources and laser systems for advanced applications.

To augment the Infinity Port, the Leica DMi8 boasts an innovative closed-loop focus system accurate to 20 nm over a 12 mm travel range, which enables researchers to scan large specimens with high precision.

Modules available for use with the DMi8 allow the user to take advantage of the full range of contrast methods from brightfield, integrated modulation contrast, phase contrast to darkfield, differential interference contrast, and fluorescence. More...


Use of different analysis channels for different fluorescence stains allows the user to analyze several aspects of a sample at the same time. An individual workflow can be assigned to each analysis channel. For example a binary reference mask can be applied to obtain object specific data, such as counting the number of spots in each nucleus. Alternatively, multiple analysis channels can be applied to the same image. Healthy cells can be counted on a stained color image in one analysis channel while a second analysis channel is used to count abnormal cells.

"The Leica DMi8 is an open and freely configurable inverted research microscope which meets the current and future needs of life scientists in a single platform," said Bernard Kleine, product manager at Leica Microsystems. "Universality and individuality have been the heart of our development work. With the Leica DMi8 we serve customer needs ranging from plain microscopy to advanced research applications, and pay heed to the fact that tasks and applications in research change. The Leica DMi8 combines the versatility of an open platform with the user-friendliness of a system solution."

Related Links:

Leica Microsystems



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.